| Product Code: ETC9561913 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Parkinsons Disease Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Parkinsons Disease Market - Industry Life Cycle |
3.4 Sweden Parkinsons Disease Market - Porter's Five Forces |
3.5 Sweden Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Sweden Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Sweden Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Sweden Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Sweden Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Sweden Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in Sweden leading to higher prevalence of Parkinson's disease |
4.2.2 Technological advancements in diagnosis and treatment options for Parkinson's disease |
4.2.3 Growing awareness and focus on neurological disorders by healthcare professionals and organizations |
4.3 Market Restraints |
4.3.1 High costs associated with Parkinson's disease medications and treatments |
4.3.2 Limited access to specialized healthcare services in certain regions of Sweden |
4.3.3 Potential side effects and complications of existing Parkinson's disease treatments |
5 Sweden Parkinsons Disease Market Trends |
6 Sweden Parkinsons Disease Market, By Types |
6.1 Sweden Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Sweden Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Sweden Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Sweden Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Sweden Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Sweden Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Sweden Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Sweden Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Sweden Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Sweden Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Sweden Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Sweden Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Sweden Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Sweden Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Sweden Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Sweden Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Sweden Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Sweden Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Sweden Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Sweden Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Sweden Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Sweden Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Sweden Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Sweden Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Sweden Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Sweden Parkinsons Disease Market Export to Major Countries |
7.2 Sweden Parkinsons Disease Market Imports from Major Countries |
8 Sweden Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of Parkinson's disease diagnosis in Sweden |
8.2 Number of clinical trials and research studies conducted on Parkinson's disease treatments in Sweden |
8.3 Percentage of Parkinson's disease patients receiving regular follow-up care and treatment compliance |
9 Sweden Parkinsons Disease Market - Opportunity Assessment |
9.1 Sweden Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Sweden Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Sweden Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Sweden Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Sweden Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Sweden Parkinsons Disease Market - Competitive Landscape |
10.1 Sweden Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Sweden Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here